Dolby Laboratories financials
$57.93−0.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Jun 26 | Q2 '26 Mar 27 | Q1 '26 Dec 26 | Q4 '25 Sep 26 | Q3 '25 Jun 27 | Q2 '25 Mar 28 | Q1 '25 Dec 27 | Q4 '24 Sep 27 | Q3 '24 Jun 28 | Q2 '24 Mar 29 | Q1 '24 Dec 29 | Q4 '23 Sep 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.0M | $395.6M | $346.7M | $307.0M | $315.5M | $369.6M | $357.0M | $304.8M | $288.8M | $364.5M | $315.6M | $290.6M |
| Gross profit | $264.7M | $350.9M | $303.5M | $267.5M | $271.5M | $333.7M | $316.2M | $270.8M | $253.2M | $325.7M | $283.5M | $255.0M |
| Gross margin | 86.8% | 88.7% | 87.5% | 87.1% | 86.1% | 90.3% | 88.6% | 88.8% | 87.7% | 89.4% | 89.8% | 87.8% |
| Operating income | $34.3M | $112.9M | $62.2M | $29.7M | $47.6M | $107.8M | $79.9M | $46.4M | $36.8M | $109.0M | $66.2M | -$3.5M |
| Net income | $28.6M | $94.9M | $53.3M | $49.3M | $46.1M | $91.8M | $67.8M | $58.6M | $38.4M | $97.8M | $67.0M | $9.2M |
| Net margin | 9.4% | 24.0% | 15.4% | 16.1% | 14.6% | 24.8% | 19.0% | 19.2% | 13.3% | 26.8% | 21.2% | 3.2% |
| Diluted EPS | $0.30 | $0.99 | $0.55 | $0.50 | $0.48 | $0.94 | $0.70 | $0.60 | $0.40 | $1.01 | $0.69 | $0.09 |
| EBITDA | $60.9M | $139.2M | $96.8M | $57.8M | $69.0M | $133.5M | $107.5M | $66.4M | $59.2M | $124.5M | $90.2M | $48.2M |
| Operating cash flow | $167.5M | $92.5M | $54.8M | $122.8M | $67.7M | $174.9M | $106.8M | $116.2M | $21.3M | $181.4M | $8.4M | $85.0M |
| Free cash flow | $152.5M | $83.4M | $50.2M | $106.6M | $61.3M | $168.0M | $100.0M | $108.8M | $13.7M | $172.5M | $2.3M | $76.8M |
| Diluted shares | 94.5M | 95.5M | 96.5M | 98.4M | 96.9M | 97.5M | 97.1M | 98.0M | 97.0M | 96.9M | 97.4M | 99.1M |
Balance sheet
| Period end | Jun 26 | Mar 27 | Dec 26 | Sep 26 | Jun 27 | Mar 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $669.4M | $594.3M | $643.8M | $701.9M | $698.6M | $626.6M |
| Short-term investments | $652.0K | $460.0K | $739.0K | $703.0K | $763.0K | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $3.16B | $3.25B | $3.19B | $3.23B | $3.20B | $3.23B |
| Total liabilities | $563.9M | $622.4M | $589.3M | $595.8M | $581.8M | $646.0M |
| Shareholders' equity | $2.59B | $2.63B | $2.60B | $2.63B | $2.61B | $2.58B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology